Position in DNLI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,837,231
+$4,328,745 QoQ
Shares Held
226,953
+188.9% QoQ
Ownership
0.142%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#59
of 290 holders
Holding Since
Mar 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026XTX Topco Ltd holds $413,089,666 across 381 Biotechnology names. DNLI ranks #12 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
30,522 | $19,031,687 | |
| 2 | ASND |
Ascendis Pharma A/S
|
43,289 | $11,546,042 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
116,611 | $8,685,187 | |
| 4 | MRNA |
Moderna, Inc.
|
123,281 | $8,633,368 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
30,496 | $7,348,621 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
61,501 | $7,052,319 | |
| 7 | CYTK |
Cytokinetics Inc
|
80,743 | $6,878,496 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
81,923 | $6,682,459 |
All Filings in DNLI
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,837,231 | 226,953 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,508,486 | 78,567 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $948,809 | 65,345 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $183,328 | 13,485 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $327,853 | 16,087 | Shares | Defined | 2025-02-13 | |
| 2023-09-30 | $921,253 | 44,656 | Shares | Defined | 2023-11-13 | |
| 2022-12-31 | $340,144 | 12,231 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $368,985 | 12,023 | Shares | Defined | 2022-11-14 | |
| 2021-03-31 | $210,299 | 3,683 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||